Zara Blake

Jackie Tohn’s Life-Saving Choice: A Double Mastectomy and a Call to Action

3 min read

How a BRCA1 genetic mutation and precancerous findings turned a personal health decision into a public mission

Horizontal landscape header image: a soft-focus medical consultation scene with subtle pink ribbons and genetic helix motifs in the background, clean and hopeful composition

Actress Jackie Tohn, known for her role in “Nobody Wants This,” revealed on May 15, 2026, that after discovering a BRCA1 genetic mutation and precancerous cells, she underwent a prophylactic double mastectomy on December 1, 2025. Her story underscores the critical importance of genetic testing, particularly for individuals with family histories or Ashkenazi Jewish ancestry, and highlights how early intervention can be transformative.

A Personal Health Revelation with Public Impact

On May 15, 2026, Jackie Tohn shared her deeply personal health journey on the TODAY show, revealing that genetic testing uncovered she carries a BRCA1 mutation and that breast tissue analysis post-surgery showed multiple precancerous cells in both breasts . Her decision to go public is rooted in a desire to raise awareness about hereditary cancer risk, especially among women who may not realize the importance of genetic screening.

The Genetic Risk That Prompted Action

Tohn’s father was diagnosed with male breast cancer in early 2025, and genetic testing revealed he carried a BRCA1 mutation, prompting Tohn to get tested herself . Upon learning she also carried the mutation, she was informed by her genetic counselor that she faced an estimated 85% lifetime risk of developing breast cancer—and a 65% risk of ovarian cancer . These staggering statistics underscore why she opted for proactive surgery.